Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab

NCT05172466 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT05172466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05172466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2022
Completion date
November 11, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis (rrms)